Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 01 2019
Historique:
received: 11 06 2018
accepted: 07 12 2018
entrez: 22 1 2019
pubmed: 22 1 2019
medline: 6 2 2019
Statut: epublish

Résumé

Mucosal melanoma is a rare and poorly characterized subtype of human melanoma. Here we perform a cross-species analysis by sequencing tumor-germline pairs from 46 primary human muscosal, 65 primary canine oral and 28 primary equine melanoma cases from mucosal sites. Analysis of these data reveals recurrently mutated driver genes shared between species such as NRAS, FAT4, PTPRJ, TP53 and PTEN, and pathogenic germline alleles of BRCA1, BRCA2 and TP53. We identify a UV mutation signature in a small number of samples, including human cases from the lip and nasal mucosa. A cross-species comparative analysis of recurrent copy number alterations identifies several candidate drivers including MDM2, B2M, KNSTRN and BUB1B. Comparison of somatic mutations in recurrences and metastases to those in the primary tumor suggests pervasive intra-tumor heterogeneity. Collectively, these studies suggest a convergence of some genetic changes in mucosal melanomas between species but also distinctly different paths to tumorigenesis.

Identifiants

pubmed: 30664638
doi: 10.1038/s41467-018-08081-1
pii: 10.1038/s41467-018-08081-1
pmc: PMC6341101
doi:

Substances chimiques

BRCA1 Protein 0
BRCA1 protein, human 0
BRCA2 Protein 0
BRCA2 protein, human 0
BUB1B protein, human 0
Cadherins 0
Cell Cycle Proteins 0
FAT4 protein, human 0
KNSTRN protein, human 0
Membrane Proteins 0
Microtubule-Associated Proteins 0
Neoplasm Proteins 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0
Tumor Suppressor Proteins 0
MDM2 protein, human EC 2.3.2.27
Proto-Oncogene Proteins c-mdm2 EC 2.3.2.27
Protein Serine-Threonine Kinases EC 2.7.11.1
PTPRJ protein, human EC 3.1.3.48
Receptor-Like Protein Tyrosine Phosphatases, Class 3 EC 3.1.3.48
PTEN Phosphohydrolase EC 3.1.3.67
PTEN protein, human EC 3.1.3.67
GTP Phosphohydrolases EC 3.6.1.-
NRAS protein, human EC 3.6.1.-

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

353

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S01473X/1
Pays : United Kingdom

Références

Nat Genet. 2008 Aug;40(8):1004-9
pubmed: 18641652
Bioorg Med Chem Lett. 2015 Oct 1;25(19):4047-56
pubmed: 26298497
Cancer Cell. 2014 Mar 17;25(3):393-405
pubmed: 24651015
Science. 2018 Nov 30;362(6418):1055-1060
pubmed: 30385465
Arch Gynecol Obstet. 2009 Nov;280(5):819-22
pubmed: 19242707
Eur J Cancer. 2015 May;51(7):791-9
pubmed: 25797355
Am J Hum Genet. 1997 Mar;60(3):505-14
pubmed: 9042909
Bioinformatics. 2012 Jul 15;28(14):1811-7
pubmed: 22581179
J Pathol. 2016 Jan;238(2):152-65
pubmed: 26354726
Cancer. 2005 Mar 1;103(5):1000-7
pubmed: 15651058
Ann Oncol. 2015 Jan;26(1):64-70
pubmed: 25319062
Br J Cancer. 2018 May;118(11):1492-1501
pubmed: 29765148
Head Neck. 2017 Feb;39(2):E20-E22
pubmed: 27726232
Nat Rev Cancer. 2004 Mar;4(3):177-83
pubmed: 14993899
Bioinformatics. 2012 Dec 15;28(24):3326-8
pubmed: 23060615
Genome Biol. 2011;12(4):R41
pubmed: 21527027
Nature. 2010 Oct 28;467(7319):1061-73
pubmed: 20981092
Science. 2013 Feb 22;339(6122):959-61
pubmed: 23348503
Front Oncol. 2018 Jan 08;7:322
pubmed: 29359122
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Cell Rep. 2017 Oct 31;21(5):1267-1280
pubmed: 29091765
Hum Mol Genet. 2005 Feb 15;14(4):555-63
pubmed: 15649950
Cancer Cell. 2017 Aug 14;32(2):204-220.e15
pubmed: 28810145
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
J Am Acad Dermatol. 2017 Aug;77(2):328-332
pubmed: 28416343
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Bioinformatics. 2015 Nov 15;31(22):3673-5
pubmed: 26163694
Lab Invest. 2017 Jun;97(6):698-705
pubmed: 28092363
Annu Rev Med. 2015;66:455-70
pubmed: 25341009
J Vet Intern Med. 1995 Sep-Oct;9(5):291-7
pubmed: 8531173
Int J Mol Sci. 2018 Mar 10;19(3):
pubmed: 29534457
Nat Genet. 2015 Dec;47(12):1402-7
pubmed: 26551669
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Curr Oncol Rep. 2018 Mar 23;20(3):28
pubmed: 29569184
Genes Dev. 2012 Jun 1;26(11):1131-55
pubmed: 22661227
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 19;370(1673):
pubmed: 26056372
J Pathol. 2013 Jul;230(3):261-9
pubmed: 23620124
PLoS Genet. 2018 Sep 6;14(9):e1007589
pubmed: 30188888
Ann Transl Med. 2015 Sep;3(15):210
pubmed: 26488006
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
Oncoimmunology. 2017 Nov 6;7(2):e1390640
pubmed: 29308317
Nat Genet. 1994 Dec;8(4):392-8
pubmed: 7894492
Int J Mol Sci. 2018 Jan 30;19(2):
pubmed: 29385676
Chromosome Res. 2015 Jun;23(2):171-86
pubmed: 25511566
Nature. 2017 Nov 23;551(7681):517-520
pubmed: 29132144
Nat Genet. 2014 May;46(5):478-481
pubmed: 24686849
Nat Genet. 2011 Dec 25;44(2):133-9
pubmed: 22197931
Cancer. 2017 Jun 1;123(S11):2089-2103
pubmed: 28543694
Brain Tumor Pathol. 2018 Apr;35(2):127-130
pubmed: 29476293
J Biol Chem. 2006 Nov 3;281(44):33036-44
pubmed: 16905769
Genome Res. 2006 Sep;16(9):1149-58
pubmed: 16899652
Pigment Cell Melanoma Res. 2016 May;29(3):266-83
pubmed: 26833684
J Pathol. 2018 Mar;244(3):358-366
pubmed: 29230811
N Engl J Med. 2005 Nov 17;353(20):2135-47
pubmed: 16291983
Br J Cancer. 2001 Jan 5;84(1):72-9
pubmed: 11139316
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Cancer Res. 2017 Aug 15;77(16):4268-4278
pubmed: 28646021
Nucleic Acids Res. 2015 Jan;43(Database issue):D777-83
pubmed: 25404132
Melanoma Res. 2017 Jun;27(3):189-199
pubmed: 28296713
Int J Cancer. 2016 Oct 1;139(7):1557-63
pubmed: 27194394
Nat Genet. 2014 Oct;46(10):1060-2
pubmed: 25194279
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
BMC Genomics. 2015 Aug 01;16:569
pubmed: 26231518
J Hered. 2005;96(7):764-5
pubmed: 16251512
Nat Commun. 2018 Jan 10;9(1):144
pubmed: 29321523
N Engl J Med. 2010 Dec 30;363(27):2628-37
pubmed: 21190457
Mamm Genome. 2001 Jun;12(6):450-5
pubmed: 11353392
Nat Rev Dis Primers. 2015 Apr 23;1:15003
pubmed: 27188223

Auteurs

Kim Wong (K)

Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.

Louise van der Weyden (L)

Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.

Courtney R Schott (CR)

Department of Pathobiology, University of Guelph, 50 Stone Road E., Guelph, ON, N1G 2W1, Canada.

Alastair Foote (A)

Rossdales Equine Hospital and Diagnostic Centre, High Street, Newmarket, Suffolk, CB8 8JS, UK.

Fernando Constantino-Casas (F)

Department of Veterinary Medicine, Cambridge Veterinary School, University of Cambridge, Cambridge, CB3 0ES, UK.

Sionagh Smith (S)

The Royal (Dick) School of Veterinary Studies and The Roslin Institute, Easter Bush Campus, Midlothian, EH25 9RG, UK.

Jane M Dobson (JM)

Department of Veterinary Medicine, Cambridge Veterinary School, University of Cambridge, Cambridge, CB3 0ES, UK.

Elizabeth P Murchison (EP)

Department of Veterinary Medicine, Cambridge Veterinary School, University of Cambridge, Cambridge, CB3 0ES, UK.

Hong Wu (H)

Departments of Dermatology and Pathology, University of California, San Francisco, CA, 94143, USA.

Iwei Yeh (I)

Departments of Dermatology and Pathology, University of California, San Francisco, CA, 94143, USA.

Douglas R Fullen (DR)

Departments of Pathology and Dermatology, University of Michigan Medical School, 3261 Medical Science I, 1301 Catherine, Ann Arbor, MI, 48109-5602, USA.

Nancy Joseph (N)

Departments of Dermatology and Pathology, University of California, San Francisco, CA, 94143, USA.

Boris C Bastian (BC)

Departments of Dermatology and Pathology, University of California, San Francisco, CA, 94143, USA.

Rajiv M Patel (RM)

Departments of Pathology and Dermatology, University of Michigan Medical School, 3261 Medical Science I, 1301 Catherine, Ann Arbor, MI, 48109-5602, USA.

Inigo Martincorena (I)

Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.

Carla Daniela Robles-Espinoza (CD)

Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Campus Juriquilla, Blvd Juriquilla 3001, Santiago de Querétaro, 76230, Mexico.

Vivek Iyer (V)

Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.

Marieke L Kuijjer (ML)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, 02215, USA.
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Faculty of Medicine, University of Oslo, 0349, Oslo, Norway.

Mark J Arends (MJ)

University of Edinburgh, Division of Pathology, Centre for Comparative Pathology, Cancer Research UK Edinburgh Centre, Institute of Genetics & Molecular Medicine, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XR, UK.

Thomas Brenn (T)

Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Department of Pathology and Laboratory Medicine, Cumming School of Medicine and Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, T2L 2K8, Canada.

Paul W Harms (PW)

Departments of Pathology and Dermatology, University of Michigan Medical School, 3261 Medical Science I, 1301 Catherine, Ann Arbor, MI, 48109-5602, USA.

Geoffrey A Wood (GA)

Department of Pathobiology, University of Guelph, 50 Stone Road E., Guelph, ON, N1G 2W1, Canada.

David J Adams (DJ)

Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. da1@sanger.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH